1,119
Participants
Start Date
May 25, 2017
Primary Completion Date
May 4, 2018
Study Completion Date
May 4, 2018
Glycopyrronium/Formoterol Fumarate
Metered dose inhaler (MDI), contains glycopyrronium/formoterol fumarate fixed-dose combination 7.2/4.8 μg per actuation
umeclidinium/vilanterol
Dry powder inhaler (DPI), Each metered dose contains umeclidinium/vilanterol 62.5/ 25μg fixed-dose combination per inhalation
Research Site, Sofia
Research Site, Budapest
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Dupnitsa
Research Site, Dupnitsa
Research Site, Balassagyarmat
Research Site, Razlog
Research Site, Petrich
Research Site, Komárom
Research Site, Kozloduy
Research Site, Miskolc
Research Site, Vidin
Research Site, Plovdiv
Research Site, Debrecen
Research Site, Hajdúnánás
Research Site, Püspökladány
Research Site, Pazardzhik
Research Site, Smolyan
Research Site, Vásárosnamény
Research Site, Pleven
Research Site, Stara Zagora
Research Site, Haskovo
Research Site, Rousse
Research Site, Komló
Research Site, Farkasgyepü
Research Site, Siófok
Research Site, Sliven
Research Site, Varna
Research Site, Szombathely
Research Site, The Bronx
Research Site, Pittsburgh
Research Site, Vinnytsia
Research Site, Vinnytsia
Research Site, Besançon
Research Site, Gastonia
Research Site, Spartanburg
Research Site, Brest
Research Site, Greenville
Research Site, Lawrenceville
Research Site, Rincon
Research Site, Hollywood
Research Site, Pessac
Research Site, Montpellier
Research Site, Poltava
Research Site, Lutsk
Research Site, Dublin
Research Site, Nantes
Research Site, Farmington Hills
Research Site, Reims
Research Site, Chernivtsi
Research Site, Chernivtsi
Research Site, Kharkiv
Research Site, Kharkiv
Research Site, Kharkiv
Research Site, Odesa
Research Site, Zaporizhzhia
Research Site, Lyon
Research Site, Sherman
Research Site, Ivano-Frankivsk
Research Site, Tomball
Research Site, Lviv
Research Site, Tempe
Research Site, Poitiers
Research Site, Escondido
Research Site, Sacramento
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Smolensk
Research Site, Ryazan
Research Site, Saratov
Research Site, Izhevsk
Research Site, Ulyanovsk
Research Site, Penza
Research Site, Penza
Research Site, Chelyabinsk
Research Site, Yekaterinburg
Research Site, Novosibirsk
Research Site, Tomsk
Research Site, Barnaul
Research Site, Barnaul
Research Site, Sherwood Park
Research Site, Winnipeg
Research Site, Truro
Research Site, Burlington
Research Site, Burlington
Research Site, Etobicoke
Research Site, Windsor
Research Site, Windsor
Research Site, Gatineau
Research Site, Lévis
Research Site, Québec
Research Site, Québec
Research Site, Québec
Research Site, Saint-Charles-Borromée
Research Site, Debrecen
Research Site, Szeged
Research Site, Kyiv
Research Site, Kyiv
Lead Sponsor
Collaborators (2)
Parexel International Ltd
UNKNOWN
Cognizant Technology Solution
UNKNOWN
CISCRP
INDUSTRY
eResearchTechnology
INDUSTRY
QuintilesIMS Limited
UNKNOWN
Corporate Translations Inc
UNKNOWN
AstraZeneca
INDUSTRY